OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Zongertinib (BI 1810631), an irreversible HER2 TKI, spares EGFR signaling and improves therapeutic response in preclinical models and patients with HER2-driven cancers
Birgit Wilding, Lydia Woelflingseder, Anke Baum, et al.
Cancer Discovery (2024) Vol. 15, Iss. 1, pp. 119-138
Open Access | Times Cited: 6
Birgit Wilding, Lydia Woelflingseder, Anke Baum, et al.
Cancer Discovery (2024) Vol. 15, Iss. 1, pp. 119-138
Open Access | Times Cited: 6
Showing 6 citing articles:
Comprehensive characterization of early-onset lung cancer, in Chinese young adults
Ye Tian, Rui Ma, Wenchang Zhao, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Ye Tian, Rui Ma, Wenchang Zhao, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Trastuzumab rezetecan, a new antibody–drug conjugate in HER2-mutated NSCLC
Wolfgang M. Brueckl
The Lancet Oncology (2025)
Closed Access
Wolfgang M. Brueckl
The Lancet Oncology (2025)
Closed Access
HER2-Selective Tyrosine Kinase Inhibitor, Zongertinib (BI 1810631), in Patients With Advanced/Metastatic Solid Tumors With HER2 Alterations: A Phase Ia Dose-Escalation Study
John V. Heymach, Frans L. Opdam, Minal Barve, et al.
Journal of Clinical Oncology (2025)
Closed Access
John V. Heymach, Frans L. Opdam, Minal Barve, et al.
Journal of Clinical Oncology (2025)
Closed Access
First-Line Pyrotinib Combination Therapy for HER2-Mutated Advanced NSCLC: A Retrospective Cohort Analysis
Yan Xiang, Meiling Zhang, Qian Wang, et al.
Current Oncology (2025) Vol. 32, Iss. 3, pp. 148-148
Open Access
Yan Xiang, Meiling Zhang, Qian Wang, et al.
Current Oncology (2025) Vol. 32, Iss. 3, pp. 148-148
Open Access
Human Epidermal Growth Factor Receptor 2 Positive Advanced Gastric or Esophagogastric Adenocarcinoma: Reflecting on the Past to Gain a New Insights
Yu Aoki, Izuma Nakayama, Kohei Shitara
Current Oncology Reports (2025)
Closed Access
Yu Aoki, Izuma Nakayama, Kohei Shitara
Current Oncology Reports (2025)
Closed Access
Trastuzumab Deruxtecan Combination Strongly Enhances Responses and Overcomes Sotorasib Resistance inKRASG12C-Mutant NSCLC
Hilal Özakıncı, Bina Desai, Denise Kalos, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 1
Hilal Özakıncı, Bina Desai, Denise Kalos, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 1
